Search

everythinglearnresearchcommunity

for

Search:↓

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Hirsutism causes significant psychological distress in women.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Effective PCOS treatments require targeting specific signaling pathways.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Stem cells and their exosomes show promise for repairing tissues and healing wounds when delivered effectively, but more research is needed on their tracking and optimal use.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.